355 related articles for article (PubMed ID: 9113379)
1. Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between gamma 2-MSH and ACTH-(1-24).
Van Bergen P; Kleijne JA; De Wildt DJ; Versteeg DH
Br J Pharmacol; 1997 Apr; 120(8):1561-7. PubMed ID: 9113379
[TBL] [Abstract][Full Text] [Related]
2. Melanocortins and cardiovascular regulation.
Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity analysis for the effects of gamma-MSH/ACTH-like peptides on cerebral hemodynamics in rats.
Van Bergen P; Van Der Vaart JG; Kasbergen CM; Versteeg DH; De Wildt DJ
Eur J Pharmacol; 1996 Dec; 318(2-3):357-68. PubMed ID: 9016926
[TBL] [Abstract][Full Text] [Related]
5. MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias.
Guarini S; Schiöth HB; Mioni C; Cainazzo M; Ferrazza G; Giuliani D; Wikberg JE; Bertolini A; Bazzani C
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):177-82. PubMed ID: 12122505
[TBL] [Abstract][Full Text] [Related]
6. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
7. Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors.
Mioni C; Giuliani D; Cainazzo MM; Leone S; Bazzani C; Grieco P; Novellino E; Tomasi A; Bertolini A; Guarini S
Eur J Pharmacol; 2003 Sep; 477(3):227-34. PubMed ID: 14522361
[TBL] [Abstract][Full Text] [Related]
8. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones.
Ni XP; Butler AA; Cone RD; Humphreys MH
J Hypertens; 2006 Nov; 24(11):2239-46. PubMed ID: 17053546
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic actions and mechanisms of systemically administered α-MSH analogs in mice.
Rinne P; Tikka S; Mäkelä S; Streng T; Savontaus E
Peptides; 2012 Nov; 38(1):150-8. PubMed ID: 22982611
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship.
Van Bergen P; Janssen PM; Hoogerhout P; De Wildt DJ; Versteeg DH
Eur J Pharmacol; 1995 Dec; 294(2-3):795-803. PubMed ID: 8750747
[TBL] [Abstract][Full Text] [Related]
11. alpha-MSH and gamma-MSH inhibit IL-1beta induced activation of the hypothalamic-pituitary-adrenal axis through central melanocortin receptors.
Cragnolini AB; Perelló M; Schiöth HB; Scimonelli TN
Regul Pept; 2004 Nov; 122(3):185-90. PubMed ID: 15491790
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of adrenocorticotropin microinjections into the rostral ventrolateral medullary pressor area of the rat.
Kawabe T; Chitravanshi VC; Kawabe K; Sapru HN
Brain Res; 2006 Aug; 1102(1):117-26. PubMed ID: 16797500
[TBL] [Abstract][Full Text] [Related]
13. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
14. Relevance of the C-terminal Arg-Phe sequence in gamma(2)-melanocyte-stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats.
Nijsen MJ; de Ruiter GJ; Kasbergen CM; Hoogerhout P; de Wildt DJ
Br J Pharmacol; 2000 Dec; 131(7):1468-74. PubMed ID: 11090122
[TBL] [Abstract][Full Text] [Related]
15. Synchronism of pressor response and grooming behavior in freely moving, conscious rats following intracerebroventricular administration of ACTH/MSH-like peptides.
Versteeg DH; Florijn WJ; Holtmaat AJ; Gispen WH; De Wildt DJ
Brain Res; 1993 Dec; 631(2):265-9. PubMed ID: 8131054
[TBL] [Abstract][Full Text] [Related]
16. [Nle3,d-Phe6 ]-γ2 -melanocyte-stimulating hormone possesses the renal excretory but not the cardiovascular actions of the native γ2 -melanocyte-stimulating hormone in anaesthetized rats.
Cope G; Flanagan ET; Houghton BL; Walsh SA; Johns EJ; Healy V
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):5-12. PubMed ID: 23106106
[TBL] [Abstract][Full Text] [Related]
17. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
[TBL] [Abstract][Full Text] [Related]
18. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage.
Giuliani D; Mioni C; Bazzani C; Zaffe D; Botticelli AR; Capolongo S; Sabba A; Galantucci M; Iannone A; Grieco P; Novellino E; Colombo G; Tomasi A; Catania A; Guarini S
Br J Pharmacol; 2007 Mar; 150(5):595-603. PubMed ID: 17245369
[TBL] [Abstract][Full Text] [Related]
19. The differential influences of melanocortins on nociception in the formalin and tail flick tests.
Zvejniece L; Muceniece R; Krigere L; Dambrova M; Klusa VZ
Pharmacol Biochem Behav; 2006 Oct; 85(2):287-91. PubMed ID: 16970983
[TBL] [Abstract][Full Text] [Related]
20. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
